 |
|
Blood Pressure Drug Combination Reduces Heart Attack Deaths
September 17, 2008Thousands of patients with high blood pressure could benefit from changing their drug treatment regimen to reduce their risk of cardiac death.
The current U.S. hypertension treatment guidelines recommend using a thiazide diuretic - a drug that increases the volume of urine - alone as the initial drug therapy for high blood pressure. But a failure of diuretic drugs to decrease deaths from heart attacks, an important consequence of hypertension, prompted Vanderbilt University Medical Center researchers to analyze data from existing clinical trials of diuretic drugs.
They found that combining a thiazide diuretic with a "potassium-sparing" drug to treat hypertension reduced both sudden cardiac death and total coronary mortality by 40 percent. The findings call into question the current treatment guidelines.
"The recommendations can now be re-examined in light of these new findings," said John Oates, M.D., senior author of the study published in the September/October issue of the Journal of the American Society of Hypertension. The Joint National Committee, under the direction of the National Heart, Lung, and Blood Institute, publishes clinical practice guidelines for hypertension - new guidelines are expected in 2009.
Thiazide diuretics successfully reduce blood pressure for many patients, but they are also known to deplete potassium, said Oates, a professor of Medicine and hypertension specialist. This potassium "wasting" has sparked concern over the years with studies suggesting a link between potassium loss and sudden cardiac death.
Oates and colleagues examined data from controlled clinical trials that compared a thiazide diuretic/potassium-sparing (ENaC inhibitor) drug combination to placebo. They generated new, previously unpublished data on sudden death in these trials, and then analyzed the results of the trials in a meta-analysis - a statistical evaluation of data combined from multiple trials. They found a 40 percent reduction in total cardiac mortality and in sudden cardiac death in elderly patients with hypertension taking the drug combination, compared with those receiving placebo.
"It was very striking," Oates said.
The investigators also performed a new meta-analysis of the clinical trials of thiazides given without a potassium-sparing drug, adding new trials to the mix. They found no benefit in coronary mortality and a 26 percent increase in sudden death. Even though the increase was not statistically significant, it was "going in the direction in which you didn't want to go," Oates said.
Observational studies previously had found an increase in sudden cardiac death in patients taking a thiazide diuretic alone, and one showed that sudden death was greater at higher doses of thiazides, he said. Studies in animal models of heart attacks also have demonstrated that low potassium levels (caused by thiazide diuretics) can spark the abnormal heart rhythms that lead to sudden death.
Do thiazide diuretics given alone have an adverse effect of increasing the risk of sudden cardiac death in patients with high blood pressure? It's possible.
"There's biologic plausibility for an adverse effect of the thiazides," Oates said. "If it's true, it's probably the largest adverse effect in the history of modern pharmacology. The number of individuals affected over the last 50 years would be staggering."
And since the current U.S. clinical practice guidelines for hypertension recommend a thiazide diuretic without a potassium-sparing drug, millions of patients may be at increased risk of coronary death, Oates pointed out.
Oates acknowledges that potassium-sparing drugs may reduce coronary mortality through a mechanism unrelated to their prevention of potassium loss. As studies proceed to determine how these drugs reduce death risk, he said, it's time to add them to thiazides as recommended first-line treatment for high blood pressure in the elderly.
Patricia Hebert, Ph.D., Christopher Coffey, Ph.D., Daniel Byrne, Theresa Scott, Rogert Fagard, M.D., Ph.D., Jeffrey Rottman, M.D., and Katherine Murray, M.D., participated in the current study. The National Institute of General Medical Sciences supported the research. Oates is the Thomas F. Frist Sr. Professor of Medicine.
Vanderbilt University
"The recommendations can now be re-examined in light of these new findings," said John Oates, M.D., senior author of the study published in the September/October issue of the Journal of the American Society of Hypertension. The Joint National Committee, under the direction of the National Heart, Lung, and Blood Institute, publishes clinical practice guidelines for hypertension - new guidelines are expected in 2009.
Thiazide diuretics successfully reduce blood pressure for many patients, but they are also known to deplete potassium, said Oates, a professor of Medicine and hypertension specialist. This potassium "wasting" has sparked concern over the years with studies suggesting a link between potassium loss and sudden cardiac death.
Oates and colleagues examined data from controlled clinical trials that compared a thiazide diuretic/potassium-sparing (ENaC inhibitor) drug combination to placebo. They generated new, previously unpublished data on sudden death in these trials, and then analyzed the results of the trials in a meta-analysis - a statistical evaluation of data combined from multiple trials. They found a 40 percent reduction in total cardiac mortality and in sudden cardiac death in elderly patients with hypertension taking the drug combination, compared with those receiving placebo.
"It was very striking," Oates said.
The investigators also performed a new meta-analysis of the clinical trials of thiazides given without a potassium-sparing drug, adding new trials to the mix. They found no benefit in coronary mortality and a 26 percent increase in sudden death. Even though the increase was not statistically significant, it was "going in the direction in which you didn't want to go," Oates said.
Observational studies previously had found an increase in sudden cardiac death in patients taking a thiazide diuretic alone, and one showed that sudden death was greater at higher doses of thiazides, he said. Studies in animal models of heart attacks also have demonstrated that low potassium levels (caused by thiazide diuretics) can spark the abnormal heart rhythms that lead to sudden death.
Do thiazide diuretics given alone have an adverse effect of increasing the risk of sudden cardiac death in patients with high blood pressure? It's possible.
"There's biologic plausibility for an adverse effect of the thiazides," Oates said. "If it's true, it's probably the largest adverse effect in the history of modern pharmacology. The number of individuals affected over the last 50 years would be staggering."
And since the current U.S. clinical practice guidelines for hypertension recommend a thiazide diuretic without a potassium-sparing drug, millions of patients may be at increased risk of coronary death, Oates pointed out.
Oates acknowledges that potassium-sparing drugs may reduce coronary mortality through a mechanism unrelated to their prevention of potassium loss. As studies proceed to determine how these drugs reduce death risk, he said, it's time to add them to thiazides as recommended first-line treatment for high blood pressure in the elderly.
Patricia Hebert, Ph.D., Christopher Coffey, Ph.D., Daniel Byrne, Theresa Scott, Rogert Fagard, M.D., Ph.D., Jeffrey Rottman, M.D., and Katherine Murray, M.D., participated in the current study. The National Institute of General Medical Sciences supported the research. Oates is the Thomas F. Frist Sr. Professor of Medicine.
Vanderbilt University
Hypertension Current Events and Hypertension News RSSPediatric obesity may alter thyroid function and structure
In addition to its strong associations with hypertension, cardiovascular disease, and diabetes, pediatric obesity may induce alterations in thyroid function and structure, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
Potassium loss from blood pressure drugs may explain higher risk of adult diabetes
Johns Hopkins researchers have discovered that a drop in blood potassium levels caused by diuretics commonly prescribed for high blood pressure could be the reason why people on those drugs are at risk for developing type 2 diabetes.
Mechanisms of cardiovascular disease and cancer give clues to new therapies
Cardiovascular conditions leading to heart attacks and strokes are treated quite separately from common cancers of the prostate, breast or lung, but now turn out to involve some of the same critical mechanisms at the molecular level.
Very low birth weight is a risk factor for 1 cause of CKD
Individuals who were underweight at birth are at increased risk of developing a condition called secondary focal segmental glomerulosclerosis, according to a study appearing in the January 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN).
Routine Testing After Aneurysm Coiling Carries Low Risk
A very low risk of complication is associated with a routine test that determines whether a brain aneurysm treated with endovascular coiling has started to recur, a study led by the University of Cincinnati Neuroscience Institute has shown.
Low risk for heart attack? Could an ultrasound hold the answer?
By adding the results of an imaging technique to the traditional risk factors for coronary heart disease, doctors at Baylor College of Medicine in Houston found they were able to improve prediction of heart attacks in people previously considered low risk.
Study shows direct link between leptin and obesity-related cardiovascular disease
Obese people who don't have high cholesterol or diabetes might think they're healthy - despite the extra pounds.
Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes
Low-dose aspirin as primary prevention did not appear to significantly reduce the risk of a combined end point of coronary, cerebrovascular and peripheral vascular events in patients with type 2 diabetes, according to a new study in JAMA.
Pregnancy diabetes doubles the risk of language delay in children
Children born to mothers with pregnancy-related diabetes run twice the risk of language development problems, according to a research team directed by Professor Ginette Dionne of Université Laval's School of Psychology. Details of this discovery are published in the most recent issue of the scientific journal Pediatrics.
Pregnancy disorder signals need to screen for heart disease, study shows
High blood pressure experienced during pregnancy could be a woman's earliest warning that she is at risk of developing heart disease - the number one killer of Canadian women - says Queen's University professor of Obstetrics and Gynecology, Graeme Smith.
More Hypertension Current Events and Hypertension News Articles
 | What Your Doctor May Not Tell You About(TM): Hypertension: The Revolutionary Nutrition and Lifestyle Program to Help Fight High Blood Pressure (What Your Doctor May Not Tell You About...) by Mark C. Houston, Barry Fox, Nadine Taylor A revolutionary, all- natural treatment program for reversing the 'silent killer' affecting more than 50 million Americans. Hypertension is a dangerous and deadly disease. There are no symptoms, so most sufferers have no idea anything is wrong-making more than 45 million Americans ticking time bombs. And while there are many drugs on the market that combat this condition, the costs and side... |
 | Reversing Hypertension: A Vital New Program to Prevent, Treat, and Reduce High Blood Pressure by Julian Whitaker It strikes one in four North Americans without warning it triples your risk of dying from a heart attack it increases your risk of stroke sevenfold it can lead to kidney disease, diabetes, and blindness and to fight it, you may be taking expensiveand dangerousdrugs. Now Dr. Julian Whitaker, a leading champion of nutritional medicine unleashes a new weapon in the war against... |
 | The DASH Diet for Hypertension by Thomas J. Moore, Mark Jenkins More than 50 million Americans suffer from high blood pressure, and most of them control it by taking prescription drugs with potentially dangerous side effects. But there is a natural, affordable, and easy-to-manage alternative to medication: the DASH (Dietary Approaches to Stop Hypertension) diet. Developed by a world-class team of doctors and nutritionists, the DASH diet is clinically proven... |
 | Pulmonary Hypertension (Contemporary Cardiology) (Contemporary Cardiology) This timely volume addresses the areas of pathophysiology and therapy of pulmonary hypertension, which have seen exciting developments over the past decade. The discoveries of endothelin overexpression as well as prostacyclin and nitric oxide deficiency in association with pulmonary hypertension have led to important therapeutic insights. In addition, the identification of genes associated with... |
 | Healing Hypertension: A Revolutionary New Approach by Samuel J. Mann A PIONEERING APPROACH TO OVERCOMING HIGH BLOOD PRESSURE If you are one of the millions of people diagnosed with high blood pressure, this groundbreaking book can change your life. Unique in combining a medical and a psychological approach, Samuel J. Mann, M.D., explains:How you can tell whether or not your high blood pressure is related to emotionsHow to find the medication best suited for... |
 | Clinical Management of Hypertension, 8th Edition by Marvin Moser The eighth edition of Clinical Management of Hypertension continues to update hypertension treatment recommendations with additions and interpretations of new data from treatment trials and guideline comittees. The management guidelines of the Seventh Joint National Committee (JNC) on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure are again reviewed and critiqued in view... |
 | The Heartmath Approach to Managing Hypertension: The Proven, Natural Way to Lower Your Blood Pressure (Heartmath) by Bruce C., M.D. Wilson, Doc Childre High blood pressure is a national epidemic. It’s a silent killer, a dangerous condition that affects one in four Americans, most of whom have no idea they are at risk for higher rates of heart disease, stroke, and other life-threatening problems. Conventional treatments for hypertension involve drugs, and these can have considerable side effects and may not be ultimately succeed in getting... |
 | Hypertension Primer: The Essentials of High Blood Pressure by American Heart Association Council on High Blood Pressure Research State Univ. of New York, Buffalo. Text provides current information on the expanding field of hypertension. Presents genetics, molecular and cellular mechanisms, population medicine, and clinical management of the disease. Emphasizes drugs used for management and specific management issues. Halftone charts and graphs. Extensive references. Previous edition: c2000.... |
 | Control High Blood Pressure Without Drugs: A Complete Hypertension Handbook by Robert Rowan Now completely revised and updated, the proven hypertension treatment plan that reduces your reliance on potentially harmful medications Hypertension is called the silent disease because it often gives no warning signs or symptoms. Its impact can be devastating: Both coronary heart disease and strokes are closely related to hypertension. But there is hope. In this fully updated and revised... |
 | Oxford American Handbook of Nephrology and Hypertension (Oxford American Handbooks in Medicine) by Paul Scheel, Michael Choi Written by leading American practitioners, the Oxford American Handbooks of Medicine each offer a pocket-sized overview of an entire specialty, featuring instant access to guidance on the conditions that are most likely to be encountered. Precise and prescriptive, the handbooks offer up-to-date advice on examination, investigations, common procedures, and in-patient care. These books will be... |
| © 2008 BrightSurf.com |